Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Hyperliquid Lists MON-USD Perpetuals Ahead of Hotly Anticipated Monad Airdrop

Hyperliquid Lists MON-USD Perpetuals Ahead of Hotly Anticipated Monad Airdrop

CryptoNewsNetCryptoNewsNet2025/10/08 19:06
By:coindesk.com

Hyperliquid, the decentralized perpetuals exchange, announced Wednesday that it has listed MON-USD hyperps, allowing traders to go long or short the token in a pre-market phase.

MON is the native token of Monad, a Layer 1 blockchain designed to be fully compatible with the Ethereum Virtual Machine (EVM) — a feature that makes it easier for developers to migrate their applications from Ethereum.

Both Hyperliquid’s announcement and Monad’s recent posts suggest that an airdrop may be imminent, with the project’s official teasing their “airdrop claim loading” feature reaching 98% on Oct. 8, according to Monad’s latest update on X.

Based on trading in the MON-USD hyperp, priced near $0.13, Monad’s fully diluted valuation (FDV) stands at approximately $13 billion, with 100 billion MON tokens expected to be distributed through the airdrop.

The new MON market has already seen strong activity, recording $28 million in trading volume over the past 24 hours on the decentralized exchange.

Read more: Ethereum L1 Monad Joins Forces With Orderly Network for DeFi Boost

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

AstraZeneca invests $2 billion in Summit, optimistic about Akeso's Ivose

This 18.6% premium subscription is not only a substantial endorsement, but both parties will also deeply collaborate on the joint development of combination therapies such as ADCs. The core of this deal is Akeso's Ivonescimab—the world’s first PD-1/VEGF bispecific antibody, and so far the only drug to have surpassed "K-drug" in head-to-head trials on both PFS and OS endpoints. The median OS reached 30.8 months, compared to 22.6 months for "K-drug", representing a 27% reduction in risk of death.

华尔街见闻•2026/09/29 00:26

AMD (AMD.US) Surpasses $1 Trillion Market Cap and Begins Competing for "Computing Power Definition Rights"! Officially Announces $8.2 Billion Acquisition of Fei-Fei Li's World Labs

AMD has agreed to acquire World Labs for $8.2 billion, thereby gaining access to the artificial intelligence startup founded by industry pioneer and researcher Fei-Fei Li. This acquisition is expected to help AMD plan its future hardware launches by bringing in a team of top researchers and their models, as well as deep insights into trends in the field of artificial intelligence.

智通财经•2026/09/29 00:06